Pharmacological AMP Kinase Activators Target the Nucleolar Organization and Control Cell Proliferation

Abstract

AimsPhenformin, resveratrol and AICAR stimulate the energy sensor 5′-AMP activated kinase (AMPK) and inhibit the first step of ribosome biogenesis, de novo RNA synthesis in nucleoli. Nucleolar activities are relevant to human health, because ribosome production is crucial to the development of diabetic complications. Although the function of nucleoli relies on their organization, the impact of AMPK activators on nucleolar structures is not known. Here, we addressed this question by examining four nucleolar proteins that are essential for ribosome biogenesis.MethodsKidney cells were selected as model system, because diabetic nephropathy is one of the complications associated with diabetes mellitus. To determine the impact of pharmacological agents on nucleoli, we focused on the subcellular and subnuclear distribution of B23/nucleophosmin, fibrillarin, nucleolin and RPA194. This was achieved by quantitative confocal microscopy at the single-cell level in combination with cell fractionation and quantitative Western blotting.ResultsAMPK activators induced the re-organization of nucleoli, which was accompanied by changes in cell proliferation. Among the compounds tested, phenformin and resveratrol had the most pronounced impact on nucleolar organization. For B23, fibrillarin, nucleolin and RPA194, both agents (i) altered the nucleocytoplasmic distribution and nucleolar association and (ii) reduced significantly the retention in the nucleus. (iii) Phenformin and resveratrol also increased significantly the total concentration of B23 and nucleolin.ConclusionsAMPK activators have unique effects on the subcellular localization, nuclear retention and abundance of nucleolar proteins. We propose that the combination of these events inhibits de novo ribosomal RNA synthesis and modulates cell proliferation. Our studies identified nucleolin as a target that is especially sensitive to pharmacological AMPK activators. Because of its response to pharmacological agents, nucleolin represents a potential biomarker for the development of drugs that diminish diabetic renal hypertrophy.

Quantitative analysis of the interplay between hsc70 and its co-chaperone HspBP1

“…To define the impact of a changing environment on the chaperone/co-chaperone pair hsc70/HspBP1, we evaluated endogenous proteins by quantitative immunofluorescence. This method was selected to avoid the complications associated with cell fractionation ( Kodiha et al, 2014 and references therein). The localization of hsc70 and HspBP1 was monitored in non-stressed cells, during heat shock and at different time points of post-stress recovery (1, 2 and 3 h).…”

Nucleoli and Stress Granules: Connecting Distant Relatives

“…the spatial separation of FC, DFC and GC . Such reorganization is accompanied by a redistribution of nucleolar proteins and changes in nucleolar activities . Some stressors go beyond these effects, as they induce the formation of the nucleolar aggresome, a stress‐induced nucleolar subcompartment with unique molecular make‐up .…”

Gold Nanoparticles Impinge on Nucleoli and the Stress Response in MCF7 Breast Cancer Cells

“…Specifically, B23/nucleophosmin (here referred to as B23) and nucleostemin are abundant in the granular component. RPA194, the largest and catalytic core subunit of RNA polymerase I, resides in the fibrillar component, and the multifunctional protein nucleolin associates with both the dense fibrillar and granular components ( [17,18] and references therein).…”